Concepedia

Christopher R. Behrens

CR

Statistics

Publications

10

Citations

724

H-Index

10

Active since

2004

Affiliations

UCSF Helen Diller Family Comprehensive Cancer Center(Current)

University of California, San Francisco

University of California, Berkeley

Lawrence Berkeley National Laboratory

Christopher R. Behrens is an author at UCSF Helen Diller Family Comprehensive Cancer Center specializing in biochemistry, pharmacology, and medicine.

Publications per year

2004–2020

10

Publications

10

Antibody–Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs

Christopher R. Behrens, Edward Ha, Lawrence Chinn et al. · Molecular Pharmaceutics · 2015 · 153 citations · Full text

, , +17

Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells

Daniel W. Sherbenou, Blake T. Aftab, Su Yang et al. · Journal of Clinical Investigation · 2016 · 102 citations · Full text

, , +14

PET Imaging and Biodistribution of Chemically Modified Bacteriophage MS2

Michelle E. Farkas, Ioana L. Aanei, Christopher R. Behrens et al. · Molecular Pharmaceutics · 2012 · 93 citations

, , +17

Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer

Su Yang, Yue Liu, Christopher R. Behrens et al. · JCI Insight · 2018 · 88 citations · Full text

, , +17

PapA3 Is an Acyltransferase Required for Polyacyltrehalose Biosynthesis in Mycobacterium tuberculosis

Stavroula K. Hatzios, Michael W. Schelle, Cynthia M. Holsclaw et al. · Journal of Biological Chemistry · 2009 · 65 citations · Full text

, , +15

1–5 of 10